News

Clinical Trials Arena on MSN2d
Galderma shares new interim analysis data from trial for prurigo nodularis
Subjects in the trial saw clearance or near-clearance of skin nodules, as measured by the Investigator’s Global Assessment score.
Stocktwits on MSN2d
Regeneron, Sanofi Say Their Inflammation Drug Approved By FDA For Rare Skin Disease Affecting Elderly, But Retail Stays Dull
Regeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNY) on Friday announced that the U.S. Food and Drug Administration (FDA) ...
Pulse Today2d
Speediatrics: What’s causing this infant’s widespread and intensely itchy rash?
What is the likely diagnosis in this case of a persistent, widespread and intensely itchy rash that has not responded to ...
Medical Dialogues4d
SA-PCT Cleanser Effectively treats Acne without compromising Skin barrier: Study
A new study published in the Journal of Drugs in Dermatology showed that while maintaining the integrity of the skin barrier, ...
The American Journal of Managed Care5d
Topical Ruxolitinib Emerges as Promising Therapy for Diverse Inflammatory Skin Conditions
Topical ruxolitinib cream shows promise as a treatment for inflammatory skin conditions, but lacks consistent data, indicating a need for further research into its use across various dermatologic ...
Too often, Black patients get late diagnoses of deadly skin cancer
The abundance in Black skin of melanin, the pigment that gives skin its color, offers extra protection from damaging ...